AmerisourceBergen Acquires IntrinsiQ, LLC

VALLEY FORGE, Pa., Sep 06, 2011 (BUSINESS WIRE) -- AmerisourceBergen Corporation /quotes/zigman/279843/quotes/nls/abc ABC -0.13% today announced that it has completed the acquisition of IntrinsiQ, LLC, a leading provider of informatics solutions that help community oncologists make treatment decisions for their patients, for a purchase price of $35 million in cash. The acquisition is expected to be immaterial to the Company's fiscal year 2011 earnings.

IntrinsiQ will become part of ION Solutions, which is a unit of AmerisourceBergen Specialty Group. The combination of IntrinsiQ's software applications and ION Solutions' existing oncology technology platform will enhance the Company's proprietary data offerings to both physicians and manufacturers. IntrinsiQ's IntelliDose(R) software will augment ION Solutions' existing clinical, practice management and reimbursement tools to help ensure oncologists make the correct clinical dosing decisions. The additional informatics will provide practices with the intelligence they need to continue to improve patient health outcomes.

"The addition of IntrinsiQ's best in class informatics to ION Solutions' market leading portfolio of tools and services demonstrates our ongoing commitment to providing superior value to community oncology," stated James Frary, President of AmerisourceBergen Specialty Group. "Oncologists need strategic partners that can capture actionable intelligence, and the IntelliDose software and other tools will strengthen our customers' ability to meet the challenges in today's healthcare market."

"The oncology specialty market has grown incredibly complex, as doctors have more therapeutic options and face mounting pressure to run the safest, most efficient practice possible," said Jeff Forringer, Chief Executive Officer of IntrinsiQ. "For more than a decade, we've assisted practices in achieving high clinical benchmarks. By joining ION Solutions, we can provide customers with even more insight, expertise and solutions that help improve oncology care."

About ION Solutions and AmerisourceBergen

A part of AmerisourceBergen Specialty Group, ION Solutions provides technologies, resources and expertise to community-based oncologists to help improve clinical and operational management. Information on ION Solutions can be found at www.iononline.com . AmerisourceBergen is one of the world's largest pharmaceutical services companies serving the United States, Canada and selected global markets. Servicing both healthcare providers and pharmaceutical manufacturers in the pharmaceutical supply channel, the Company provides drug distribution and related services designed to reduce costs and improve patient outcomes. AmerisourceBergen's service solutions range from pharmacy automation and pharmaceutical packaging to reimbursement and pharmaceutical consulting services. With $80 billion in annualized revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs approximately 10,000 people. AmerisourceBergen is ranked #27 on the Fortune 500 list. For more information, go to www.amerisourcebergen.com .

Suggested Articles

Monday, Bernstein analysts echoed what many were probably thinking about Novo Nordisk’s Rybselsus price: “Finally we can stop talking about it.”

Low interest rates and strong stock valuations are two top reasons why U.S. drugmakers are on the move for deals.

Despite a 45% premium offered to Allergan investors through the AbbVie buyout, one investor is suing to block the deal.